Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 विचारों
• 07/14/23
0
0
एम्बेड
administrator
ग्राहकों
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां